(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)

Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.

Share Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)

Sign up to save your podcasts

Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)

Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)